Filter Search


Europe


Location Summary Deadline
Germany Medicines With The Active Ingredient Urapidil (atc: C02ca06) 2026-06-06
Germany Medicines With The Active Ingredient Alfacalcidol (atc: A11cc03) 2026-06-06
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V With The Active Ingredient Teriparatide 2026-06-06
Germany Conclusion Not Excluding Drug Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Apremilast (atc Code According To Who: L04aa32) 2026-06-06
Germany The Subject Of This Publication Is The Conclusion Of Contracts According To § 130a Abs. 8 Sgb V For Various Active Ingredients Within The Framework Of A So-called Open-house Procedure. Under The Provision Of Uniform Contractual Conditions And A Uniform Ac 2026-06-06
Germany Medicines Called Orylmyte (atc Code: V01aa03 - House Dust Mites) 2026-06-06
Bulgaria Delivery Of Medical Consumables And Dressing Materials 2026-06-06
Portugal Acquisition Of Autotransfusion Systems With Counter Placement Of Equipment 2026-06-06
Germany Medicines With The Active Ingredient Combination Betamethasone And Fusidic Acid (atc: D07cc01) 2026-06-06
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-06
Whats app